Cannabis Chart Of The Week: Revenue And EBITDA Beats Are

Nov 13, 2023 · Cannabis Chart Of The Week: Revenue And EBITDA Beats Are Great, But The Real Story Is Cash Flow From Operations ... Six of the eight had EBITDA beats that ranged …

39%
OFF

Cannabis Chart Of The Week: How Much Have MSO Valuation …

1 week from now

Apr 18, 2024 · The group EV/EBITDA went up 39% because enterprise values rose 37.9% while EBITDA estimates fell by 0.9%. In other words, the market is simply valuing a static amount of …

businessinsider.com

$1
OFF

Cannabis Industry Chart Of The Week: Q2 Earnings Releases

1 week from now

Aug 17, 2021 · Last week seven of the eleven MSOs with more than $1B market caps reported Q2 results. The chart shows the percentage difference between actual Revenue and EBITDA …

benzinga.com

$1
OFF

Cannabis Chart Of The Week: What Should EBITDA Multiples Be?

1 week from now

Apr 26, 2022 · We based our model on a hypothetical $1 of EBITDA and generated a DCF valuation of that $1 to produce an EBITDA multiple. Assumptions: Revenue growth rates 2022 …

webull.com

1%
OFF

420 Investor Review Of The Week Ending - 11/15/24 - Seeking Alpha

1 week from now

10 hours ago · Beat the Global Cannabis Stock Index fell again this week, decreasing 3.1% to $83,194, worse than the index, which was down 0.7%. In 2023, it was down 15.2%, while the …

seekingalpha.com

4%
OFF

Cannabis Chart Of The Week: EBITDA Expectations For Q3:23 And …

1 week from now

Feb 26, 2024 · The 13.4% expected growth in 2024 EBITDA is driven by a modest 5.8% growth in revenues with a 7.2% increase in EBITDA margins. We will monitor and report on revisions …

businessinsider.com

75%
OFF

Cannabis Chart Of The Week: MSO EBITDA Expectations Last Year …

1 week from now

Apr 10, 2023 · Analysts reduced consensus 2023 EBITDA estimates for the companies on this chart by 11.75% in March. Estimates are nearly 25% lower than 2022 estimates and only 9% …

businessinsider.com

$0.41
OFF

Rising High: Cannabis Firms Report Quarterly Earnings

1 week from now

1 day ago · IM Cannabis Corp. also reported Q3 earnings on Thursday with a loss per share of (C$0.41) on revenue of C$13.9M, which compared to a loss per share of (C$0.96) on revenue …

nasdaq.com

$1
OFF

Cannabis Chart Of The Week: What Should EBITDA Multiples Be?

1 week from now

Apr 26, 2022 · We based our model on a hypothetical $1 of EBITDA and generated a DCF valuation of that $1 to produce an EBITDA multiple. Assumptions: Revenue growth rates 2022 …

benzinga.com

FAQs about Cannabis Chart Of The Week: Revenue And EBITDA Beats Are Coupon?

Why did EV/EBITDA go up 39%?

The maroon line shows the percent change in enterprise value, while the orange line shows the percent change in consensus NTM EBITDA estimates. The group EV/EBITDA went up 39% because enterprise values rose 37.9% while EBITDA estimates fell by 0.9%. In other words, the market is simply valuing a static amount of EBITDA at a higher multiple. ...

What are analyst estimates of EBITDA margins in Q2?

The chart shows analyst estimates of EBITDA margins for the second quarter vs. the first quarter and the 2nd quarter of 2022 for the fourteen largest MSOs for which we have consistent analyst projections. The blue bars show Q1 23 EBITDA margins; the red bars show Q2: 23 projected EBITDA margins, and the green bars show) Q2: 22 EBITDA Margins. ...

Are EBITDA beats/misses related to stock price changes?

Unsurprisingly and consistent with prior quarters, there was virtually no correlation between either revenue or EBITDA beats/misses and stock price changes. However, the most striking aspect of the 3rd quarter releases is the Cash Flow from Operations (CFFO) figures in the graph. ...

What is the difference between 2022 adjusted EBITDA and consensus estimates?

The red bars depict actual 2022 Adjusted EBITDA, and the green bars show consensus 2023 estimates as of 4/7/23. 2022 Consensus Estimates missed the mark by a wide margin. ...

Which companies will have lower Q2 23 EBITDA margins than Q2 22?

We also expect that most companies will have lower Q2 23 EBITDA margins than Q2 22 based on commodification-based wholesale pricing pressures and inflation-driven cost increases. Ten of the fourteen companies on the chart follow this pattern. Outliers include Jushi (OTC:JUSHF), whose Q2 22 EBITDA of $0.5M missed estimates by 86%. ...

What are the EBITDA beats for terrascend vs Trulieve (tcnnf?

The beats were a bit larger and ranged from 2.2% for Trulieve (OTC:TCNNF) to 7.0% for Green Thumb (OTC:GTBIF). Six of the eight had EBITDA beats that ranged from 1.6% for Curaleaf (OTC:CURLF) to 44.0% for TerrAscend (OTC:TRSSF). MariMed (OTC:MRMD) missed by 23.8%, while Planet 13 missed by 81.8%. ...